“Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study”, J of Skin, vol. 8, no. 6, p. s506, Nov. 2024, doi: 10.25251/skin.8.supp.506.